This Month in Psychopharmacology

Low-Dose Buprenorphine May Enhance Ketamine's Antisuicidal Effects in Major Depression

Suicidal ideation in major depressive disorder (MDD) is a major cli...

Read More

Supporting Better Mental Health Outcomes Through Inclusive Care

June is Pride Month and it’s important to understand the barriers t...

Read More

PTSD Is Increasing Among US Veterans: Updated National Data Highlight the Need for Trauma-Informed Assessment

Posttraumatic stress disorder (PTSD) remains one of the most clinic...

Read More

A Novel D2/D3/5-HT7 Antagonist Shows Promise in Acute Schizophrenia

Amisulpride is a benzamide-based antipsychotic that is not approved...

Read More

Magnetic Seizure Therapy vs. Electroconvulsive Therapy for Bipolar Depression

ECT is among the most effective treatments for treatment-resistant ...

Read More

Poor Mood Response to Oral Contraceptives Linked to Higher Risk of Peripartum and Premenstrual Depression

Depressive episodes occurring at times of reproductive hormone chan...

Read More

Mirtazapine Demonstrates Efficacy in Routine Care for Methamphetamine Use Disorder

Methamphetamine use disorder affects about 7.4 million people world...

Read More

Supporting Better PTSD Care Through Clinical Education

Throughout PTSD Awareness Month, we remain committed to supporting ...

Read More

Benzodiazepine Use Linked to Reduced Risk of Catatonia Recurrence

Nearly half of catatonia patients experience recurrent episodes, wh...

Read More

Beyond the Myths: Reassessing Lithium’s Risks and Benefits

Lithium has long been a cornerstone treatment for bipolar disorder,...

Read More

World Schizophrenia Day: Education & Resources

World Schizophrenia Day is observed each year on May 24 to raise aw...

Read More

Chatbots Reinforce Users’ Psychotic Ideations

Large language model (LLM) chatbots such as ChatGPT are increasingl...

Read More